20 days and counting..............................
Post# of 72440
4/9/2019 PR
The Company is now positioning itself to further advance Brilacidin, most immediately, in its planned Phase 3 Oral Mucositis program, and in mid-stage testing for Inflammatory Bowel Disease.
Leo's email to me was on the nose. It's a waiting game and not with BP..Per Leo